Skip to main navigation Skip to search Skip to main content

Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

  • Chrysalyne D. Schmults
  • , Rachel Blitzblau
  • , Sumaira Z. Aasi
  • , Murad Alam
  • , Arya Amini
  • , Kristin Bibee
  • , Jeremy Bordeaux
  • , Pei Ling Chen
  • , Carlo M. Contreras
  • , Dominick DiMaio
  • , Jessica M. Donigan
  • , Jeffrey M. Farma
  • , Karthik Ghosh
  • , Kelly Harms
  • , Alan L. Ho
  • , John Nicholas Lukens
  • , Lawrence Mark
  • , Theresa Medina
  • , Kishwer S. Nehal
  • , Paul Nghiem
  • Kelly Olino, Soo Park, Tejesh Patel, Igor Puzanov, Jason Rich, Aleksandar Sekulic, Ashok R. Shaha, Divya Srivastava, Valencia Thomas, Courtney Tomblinson, Puja Venkat, Yaohui Gloria Xu, Siegrid Yu, Mehran Yusuf, Beth McCullough, Sara Espinosa
  • Dana-Farber Cancer Institute
  • Duke University
  • Stanford University
  • Northwestern University
  • City of Hope National Medical Center
  • Johns Hopkins University
  • Case Western Reserve University
  • University of South Florida
  • Ohio State University
  • University of Nebraska Medical Center
  • University of Utah
  • Mayo Clinic
  • University of Michigan, Ann Arbor
  • Memorial Sloan-Kettering Cancer Center
  • University of Pennsylvania
  • Indiana University Bloomington
  • University of Colorado Anschutz Medical Campus
  • Fred Hutchinson Cancer Research Center
  • Yale University
  • University of California at San Diego
  • University of Tennessee Health Science Center
  • Roswell Park Comprehensive Cancer Center
  • Washington University St. Louis
  • UT Southwestern Simmons Comprehensive Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Vanderbilt University
  • University of California at Los Angeles
  • University of Wisconsin-Madison
  • University of California at San Francisco
  • University of Alabama at Birmingham
  • National Comprehensive Cancer Network

Research output: Contribution to journalArticlepeer-review

109 Scopus citations

Abstract

Basal cell carcinoma (BCC) is the most common form of skin cancer in the United States. Due to the high frequency, BCC occurrences are not typically recorded, and annual rates of incidence can only be estimated. Current estimated rates are 2 million Americans affected annually, and this continues to rise. Exposure to radiation, from either sunlight or previous medical therapy, is a key player in BCC development. BCC is not as aggressive as other skin cancers because it is less likely to metastasize. However, surgery and radiation are prevalent treatment options, therefore disfigurement and limitation of function are significant considerations. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) outline an updated risk stratification and treatment options available for BCC.

Original languageEnglish
Pages (from-to)1181-1203
Number of pages23
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume21
Issue number11
DOIs
StatePublished - Nov 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Carcinoma, Basal Cell/diagnosis
  • Medical Oncology
  • United States/epidemiology
  • Humans
  • Sunlight
  • Skin Neoplasms/diagnosis
  • Incidence

Fingerprint

Dive into the research topics of 'Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology'. Together they form a unique fingerprint.

Cite this